{
    "Case ID": "012346",
    "Crime_Name": [
        "Trademark Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Trademark Dispute"
    ],
    "Legal_Issue": [
        "Validity of Bayer's CIRCLE DESIGN trademark application under the Trade-marks Act"
    ],
    "Governing_Law": [
        "Trade-marks Act"
    ],
    "Procedural_Stage": [
        "Appeal from Registrar's decision"
    ],
    "Evidence_Assessment": [
        "Errors in color representation (blue vs. pink), lack of clarity on size and first use date, limited distinctiveness due to common pink tablets"
    ],
    "Decision_Outcome": [
        "Bayer's trademark application rejected"
    ],
    "Burden_of_Proof": [
        "On Bayer to demonstrate compliance and distinctiveness"
    ],
    "Credibility_Factor": [
        "Evidence showed limited distinctiveness and inaccuracies in application"
    ],
    "Legal_Rule": [
        "A trademark must be distinctive, comply with statutory requirements, and not mislead; Section 30(h) requires accurate drawings"
    ],
    "Standard_of_Review": [
        "Correctness standard"
    ],
    "Procedural_Issue": [
        "Review of Registrar's decision with new evidence"
    ],
    "Grounds_for_Claim": [
        "Non-compliance with statutory requirements, lack of distinctiveness"
    ],
    "Outcome_on_Merits": [
        "Novopharm's appeal succeeds"
    ],
    "Decision_Maker": [
        "Appellate authority reviewing Registrar's decision"
    ],
    "Judicial_Review_Outcome": [
        "Appeal allowed"
    ],
    "Review_Standard": [
        "Correctness"
    ],
    "Procedural_Fairness_Assessment": [
        "New evidence considered on appeal"
    ],
    "Key_Evidence_Considered": [
        "Color representation discrepancies, size ambiguity, first use date uncertainty, market use of pink tablets"
    ],
    "Legal_Framework": [
        "Canadian Trade-marks Act"
    ],
    "Applicant_Challenge": [
        "Bayer's application challenged by Novopharm"
    ],
    "Court_Result": [
        "Rejection of Bayer's trademark application"
    ],
    "Legal_Rule_Source": [
        "Section 30(h) of the Trade-marks Act"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Novopharm opposed the application"
    ],
    "Evidence_Type": [
        "Documentary evidence, visual comparison, market usage data"
    ],
    "Remedy_Requested": [
        "Opposition to trademark registration"
    ],
    "Outcome": [
        "Bayer's application dismissed, Novopharm prevails"
    ],
    "Decision_Authority": [
        "Appellate body under s. 56 of the Trade-marks Act"
    ],
    "Remedy_Sought": [
        "Prevention of invalid trademark registration"
    ],
    "Resolution_Mechanism": [
        "Statutory appeal process"
    ],
    "Legal_Provision": [
        "Section 30(h), Section 56 of the Trade-marks Act"
    ],
    "Authority": [
        "Registrar of Trademarks, Appellate Review Body"
    ],
    "Claimant_Status": [
        "Novopharm as opponent/appellant"
    ],
    "Legal_Provision_Cited": [
        "s. 30(h), s. 56"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Inaccurate drawing, non-distinctive mark, misleading color representation"
    ],
    "Applicable_Process": [
        "Appeal under s. 56 of the Trade-marks Act"
    ],
    "Outcome_of_Review": [
        "Appeal allowed"
    ],
    "Pending_Relief_or_Application": [
        "Trademark registration application by Bayer"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Trade-marks Act, Section 30(h)"
    ]
}